Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 88.14% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Teladoc Health, Albireo Pharma and The Joint Corp
by Zacks Equity Research
Teladoc Health, Albireo Pharma and The Joint Corp are included in this blog.
Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care
by Zacks Equity Research
Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.
Is a Surprise Coming for Teladoc (TDOC) This Earnings Season?
by Zacks Equity Research
Teladoc (TDOC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc Health's (TDOC) Q4 results are expected to gain from high sales and visits volume.
How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
Teladoc (TDOC) Stock Moves -0.79%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $72.83, marking a -0.79% move from the previous day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $76.19, moving +0.9% from the previous trading session.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $79.57, marking a +1.36% move from the previous day.
What's in Store for UnitedHealth Group's (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results are likely to reflect a rise in earnings and revenues on the back of solid segmental contributions.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $82.18, marking a +0.51% move from the previous day.
Teladoc (TDOC) Ties Up to Offer Virtual Care for NLA Members
by Zacks Equity Research
Teladoc Health (TDOC) teams up with NLA in a bid to offer its comprehensive suite of virtual care services to benefit the latter's members.
Teladoc (TDOC) Falls 8.1% Despite Upbeat Revenue Guidance
by Zacks Equity Research
Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024.
Salesforce and Autohome have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Salesforce (CRM) as the Bull of the Day, and Autohome Inc. (ATHM) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Ford Motor Co. (F), eBay (EBAY), and Teladoc Health (TDOC).
Teladoc Health (TDOC) Q3 Loss Narrower Than Expected, Down Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) third-quarter results indicate improved revenues owing to higher access fees and visit fees, partly offset by elevated costs.
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 24.29% and 0.97%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Investors Book Profits Late; Q3 Reports for Ford, eBay, Teladoc
by Mark Vickery
Late-day selling in the regular session brought indexes to their lows for the day, but Ford is up in late trading on Q3 numbers.
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
by Srijita Guha
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $140.53 in the latest trading session, marking a +0.04% move from the prior day.
What's in Store for Teladoc Health's (TDOC) Earnings in Q3?
by Zacks Equity Research
Teladoc Health (TDOC) is likely to report a strong revenue outperformance for the third quarter, driven by broad-based momentum across its business and a sharp acceleration in visit-volume growth.
Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).
Earnings Preview: Teladoc (TDOC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $136.88, marking a +0.63% move from the previous day.